Poolbeg Pharma and CytoReason identify "very exciting influenza targets"

By Proactive Investors / June 29, 2023 / www.youtube.com / Article Link


Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington and CytoReason co-founder and CEO David Harel ...

Recent News

Several new entrants to TSXV large gold, including producer Asante
November 24, 2025 / www.canadianminingreport.com

Gold stocks down on metal decline, equity market slide
November 24, 2025 / www.canadianminingreport.com

Largest gold producers see strong Q3/25 earnings
November 17, 2025 / www.canadianminingreport.com

Gold stocks jump on gain in metal price
November 17, 2025 / www.canadianminingreport.com

AOCE and WB boost gold targets for 2025 significantly
November 10, 2025 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok